AMBER COFFMAN: Open Payments
NPI 1306398607 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,924 in 58 payments from 15 companies in 2025. Trend: 2023 $1,279 · 2024 $2,523 · 2025 $1,924
Food & beverage: $1,924
| Company | Payments | Amount |
|---|---|---|
| CVRx, Inc. | 5 | $522 |
| Alnylam Pharmaceuticals Inc. | 5 | $239 |
| PFIZER INC. | 11 | $213 |
| Novartis Pharmaceuticals Corporation | 6 | $170 |
| Merck Sharp & Dohme LLC | 6 | $150 |
| AstraZeneca Pharmaceuticals LP | 6 | $127 |
| Stryker Corporation | 1 | $122 |
| Amgen Inc. | 5 | $80 |
| Philips North America LLC | 3 | $79 |
| Actelion Pharmaceuticals US, Inc. | 2 | $59 |
Products named: Barostim Neo System, LEQVIO, VERQUVO, VYNDAQEL, AMVUTTRA, FLOWTRIEVER, ONPATTRO, FARXIGA.
Industry payments across FL — which companies pay providers there.
